These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 29100521)
1. DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment. Hauge A; Wegner CS; Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK J Transl Med; 2017 Nov; 15(1):225. PubMed ID: 29100521 [TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts. Wegner CS; Hauge A; Gaustad JV; Andersen LMK; Simonsen TG; Galappathi K; Rofstad EK Acta Oncol; 2017 Dec; 56(12):1754-1762. PubMed ID: 28661213 [TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure. Hompland T; Ellingsen C; Rofstad EK BMC Cancer; 2012 Nov; 12():544. PubMed ID: 23173554 [TBL] [Abstract][Full Text] [Related]
4. Connective tissue of cervical carcinoma xenografts: associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI. Hompland T; Ellingsen C; Galappathi K; Rofstad EK Acta Oncol; 2014 Jan; 53(1):6-15. PubMed ID: 23445339 [TBL] [Abstract][Full Text] [Related]
5. DCE-MRI and Quantitative Histology Reveal Enhanced Vessel Maturation but Impaired Perfusion and Increased Hypoxia in Bevacizumab-Treated Cervical Carcinoma. Hauge A; Gaustad JV; Huang R; Simonsen TG; Wegner CS; Andersen LMK; Rofstad EK Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):666-676. PubMed ID: 30858145 [TBL] [Abstract][Full Text] [Related]
6. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820 [TBL] [Abstract][Full Text] [Related]
7. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights. Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523 [TBL] [Abstract][Full Text] [Related]
8. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts. Ellingsen C; Hompland T; Galappathi K; Mathiesen B; Rofstad EK Radiother Oncol; 2014 Feb; 110(2):335-41. PubMed ID: 24231244 [TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: pharmacokinetic analysis and correlation to tumor histomorphology. Ellingsen C; Egeland TA; Galappathi K; Rofstad EK Radiother Oncol; 2010 Nov; 97(2):217-24. PubMed ID: 20656365 [TBL] [Abstract][Full Text] [Related]
10. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses. Lund KV; Simonsen TG; Kristensen GB; Rofstad EK Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487 [TBL] [Abstract][Full Text] [Related]
11. Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging. Gulliksrud K; Hompland T; Galappathi K; Rofstad EK Radiother Oncol; 2011 Oct; 101(1):217-22. PubMed ID: 21840612 [TBL] [Abstract][Full Text] [Related]
12. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer. Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852 [TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts. Øvrebø KM; Ellingsen C; Hompland T; Rofstad EK Acta Oncol; 2013 Apr; 52(3):604-11. PubMed ID: 22671573 [TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts. Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model. Ceelen W; Smeets P; Backes W; Van Damme N; Boterberg T; Demetter P; Bouckenooghe I; De Visschere M; Peeters M; Pattyn P Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1188-96. PubMed ID: 16457965 [TBL] [Abstract][Full Text] [Related]
16. Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model. Ahn SJ; An CS; Koom WS; Song HT; Suh JS Korean J Radiol; 2011; 12(6):722-30. PubMed ID: 22043155 [TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images. Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783 [TBL] [Abstract][Full Text] [Related]
18. The Microenvironment of Cervical Carcinoma Xenografts: Associations with Lymph Node Metastasis and Its Assessment by DCE-MRI. Ellingsen C; Walenta S; Hompland T; Mueller-Klieser W; Rofstad EK Transl Oncol; 2013; 6(5):607-17. PubMed ID: 24151541 [TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model. Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584 [TBL] [Abstract][Full Text] [Related]
20. DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts. Wegner CS; Hauge A; Simonsen TG; Gaustad JV; Andersen LMK; Rofstad EK Neoplasia; 2018 Jul; 20(7):734-744. PubMed ID: 29886124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]